Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M]

Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M]: A Powerful Tool for Research

The Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M] is a highly specialized research tool designed for the detection and analysis of CD15, a glycoprotein expressed on the surface of various cell types, including myeloid cells. This antibody is produced through a rigorous process involving the cloning of mouse cells to generate a monoclonal antibody with high specificity and affinity for CD15. The Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M] is ideal for various applications, including immunohistochemistry (IHC-p) and immunofluorescence (IF), making it a versatile choice for researchers in the fields of immunology, oncology, and hematology.

• High specificity and affinity for CD15
• Applications in IHC-p and IF
• Enhanced research capabilities in immunology and oncology

Key Features and Specifications of Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M]

The Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M] is produced using synthetic peptides as the immunogen, ensuring the highest level of purity and consistency. This antibody is unconjugated, allowing for flexibility in conjugation with various labels and secondary antibodies. The antibody is purified using Protein A purification, which guarantees a high degree of purity and minimal contamination. The Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M] is available in a concentration of 1 mg/mL and is supplied in a phosphate buffered solution containing stabilizers, protein protectants, and 50% glycerol.

• Produced using synthetic peptides for high purity
• Unconjugated for flexibility in conjugation
• Protein A purification for high purity and minimal contamination

Applications and Benefits of Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M]

The Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M] is a valuable tool for researchers studying the role of CD15 in various diseases, including liver lymphoma, colon adenocarcinoma, and other malignancies. This antibody can be used to detect CD15 expression in tissue samples, aiding in the diagnosis and monitoring of diseases. Additionally, the Last Chance Cd15 Monoclonal Antibody Now 50% Cheaper [XfehB81M] can be utilized in stem cell research to identify and isolate myeloid cells. The antibody's high specificity and affinity, combined with its versatility in various applications, make it an essential addition to any research lab.

• Useful in diagnosing and monitoring diseases
• Essential for stem cell research
• Enhances research capabilities in immunology, oncology, and hematology